Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CDNANASDAQ:PRVANASDAQ:SGRYNASDAQ:SHC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDNACareDx$17.52+2.6%$17.25$13.18▼$34.84$975.53M2.27960,136 shs340,824 shsPRVAPrivia Health Group$23.03+0.9%$23.34$16.37▼$26.09$2.81B0.87738,859 shs363,164 shsSGRYSurgery Partners$23.380.0%$22.32$19.50▼$33.97$3.00B1.961.10 million shs659,201 shsSHCSotera Health$12.30+0.9%$11.68$9.53▼$17.08$3.49B1.881.20 million shs372,518 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDNACareDx+0.83%+0.77%+13.87%-15.86%+31.28%PRVAPrivia Health Group-0.13%-0.13%-2.10%-10.54%+31.43%SGRYSurgery Partners-1.56%+2.59%+1.34%-1.72%-15.25%SHCSotera Health-0.57%+0.25%-1.53%+6.28%+9.03%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCDNACareDx3.6147 of 5 stars3.31.00.04.22.90.80.6PRVAPrivia Health Group3.5095 of 5 stars3.52.00.00.02.93.31.9SGRYSurgery Partners2.5789 of 5 stars3.41.00.00.02.00.82.5SHCSotera Health2.6823 of 5 stars3.40.00.00.03.23.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDNACareDx 2.67Moderate Buy$30.3373.14% UpsidePRVAPrivia Health Group 3.00Buy$27.7720.58% UpsideSGRYSurgery Partners 2.70Moderate Buy$33.5643.52% UpsideSHCSotera Health 2.80Moderate Buy$15.8028.46% UpsideCurrent Analyst Ratings BreakdownLatest CDNA, SHC, PRVA, and SGRY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025PRVAPrivia Health GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $32.005/27/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $24.005/27/2025SGRYSurgery PartnersBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$25.00 ➝ $24.005/5/2025CDNACareDxStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$40.00 ➝ $40.005/5/2025CDNACareDxHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$25.00 ➝ $25.005/5/2025SHCSotera HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$14.00 ➝ $17.004/28/2025PRVAPrivia Health GroupJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$29.00 ➝ $29.004/23/2025SHCSotera HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.004/21/2025SGRYSurgery PartnersBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$35.00 ➝ $35.004/17/2025CDNACareDxThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$34.00 ➝ $26.004/15/2025PRVAPrivia Health GroupRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$24.00 ➝ $26.00(Data available from 6/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDNACareDx$346.42M2.82N/AN/A$4.83 per share3.63PRVAPrivia Health Group$1.80B1.56$0.23 per share98.24$5.14 per share4.48SGRYSurgery Partners$3.17B0.94$1.63 per share14.30$23.99 per share0.97SHCSotera Health$1.11B3.15$1.20 per share10.27$1.57 per share7.83Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDNACareDx-$190.28M$1.15N/AN/AN/A-45.90%-53.70%-30.42%7/30/2025 (Estimated)PRVAPrivia Health Group$23.08M$0.12230.3285.303.470.75%2.02%1.21%8/14/2025 (Estimated)SGRYSurgery Partners-$11.90M-$1.53N/A28.8619.21-2.03%2.85%1.22%8/5/2025 (Estimated)SHCSotera Health$51.38M$0.0849.2017.57N/A6.31%42.27%6.02%8/4/2025 (Estimated)Latest CDNA, SHC, PRVA, and SGRY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025SGRYSurgery Partners$0.08$0.04-$0.04-$0.30$777.77 million$776.00 million5/1/2025Q1 2025SHCSotera Health$0.12$0.14+$0.02-$0.05$245.56 million$254.52 million4/30/2025Q1 2025CDNACareDx$0.06$0.09+$0.03-$0.19$84.56 million$84.69 million3/3/2025Q4 2024SGRYSurgery Partners$0.38$0.39+$0.01-$0.86$828.09 million$864.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCDNACareDxN/AN/AN/AN/AN/APRVAPrivia Health GroupN/AN/AN/AN/AN/ASGRYSurgery PartnersN/AN/AN/AN/AN/ASHCSotera HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDNACareDxN/A4.103.87PRVAPrivia Health GroupN/A1.781.78SGRYSurgery Partners0.991.801.66SHCSotera Health4.912.882.61Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDNACareDxN/APRVAPrivia Health Group94.48%SGRYSurgery PartnersN/ASHCSotera Health91.03%Insider OwnershipCompanyInsider OwnershipCDNACareDx4.90%PRVAPrivia Health Group10.70%SGRYSurgery Partners2.30%SHCSotera Health47.55%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCDNACareDx74055.68 million51.01 millionOptionablePRVAPrivia Health Group810121.92 million102.96 millionOptionableSGRYSurgery Partners12,200128.16 million124.19 millionOptionableSHCSotera Health3,000283.86 million127.12 millionOptionableCDNA, SHC, PRVA, and SGRY HeadlinesRecent News About These CompaniesNuveen Asset Management LLC Has $5.56 Million Stake in Sotera Health (NASDAQ:SHC)June 1 at 3:45 AM | marketbeat.comNeo Ivy Capital Management Increases Stake in Sotera Health (NASDAQ:SHC)May 26, 2025 | marketbeat.comSotera Health's SWOT analysis: stock outlook amid litigation, growth focusMay 26, 2025 | investing.com1,000,000 Shares in Sotera Health (NASDAQ:SHC) Acquired by Ananym Capital Management LPMay 24, 2025 | marketbeat.comSotera Health (NASDAQ:SHC) Shares Bought by Two Seas Capital LPMay 23, 2025 | marketbeat.comSculptor Capital LP Invests $68.40 Million in Sotera Health (NASDAQ:SHC)May 19, 2025 | marketbeat.comNorthern Trust Corp Purchases 254,768 Shares of Sotera Health (NASDAQ:SHC)May 16, 2025 | marketbeat.comSHC Q1 Earnings Call: Sotera Health Outperforms Expectations, Highlights Resilient Service DemandMay 15, 2025 | finance.yahoo.comJanus Henderson Group PLC Has $106.46 Million Holdings in Sotera Health (NASDAQ:SHC)May 15, 2025 | marketbeat.comIrenic Capital Management LP Increases Holdings in Sotera Health (NASDAQ:SHC)May 13, 2025 | marketbeat.comSotera Health (NASDAQ:SHC) Shares Acquired by D. E. Shaw & Co. Inc.May 13, 2025 | marketbeat.comBrevan Howard Capital Management LP Purchases 44,280 Shares of Sotera Health (NASDAQ:SHC)May 10, 2025 | marketbeat.comAxa S.A. Boosts Stock Holdings in Sotera Health (NASDAQ:SHC)May 10, 2025 | marketbeat.comSpotting Winners: Sotera Health Company (NASDAQ:SHC) And Research Tools & Consumables Stocks In Q1May 9, 2025 | finance.yahoo.comThere May Be Reason For Hope In Sotera Health's (NASDAQ:SHC) Disappointing EarningsMay 9, 2025 | finance.yahoo.comSotera Health (NASDAQ:SHC) Trading Up 5.1% - What's Next?May 7, 2025 | marketbeat.comSotera Health (NASDAQ:SHC) Upgraded to "Buy" at The Goldman Sachs GroupMay 7, 2025 | marketbeat.comAQR Capital Management LLC Decreases Holdings in Sotera Health (NASDAQ:SHC)May 7, 2025 | marketbeat.comDimensional Fund Advisors LP Buys 673,979 Shares of Sotera Health (NASDAQ:SHC)May 6, 2025 | marketbeat.comGoldman Sachs Upgrades Sotera Health (SHC)May 5, 2025 | msn.comWhy Sotera Health Company (SHC) Stock Is Trading Up TodayMay 5, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCDNA, SHC, PRVA, and SGRY Company DescriptionsCareDx NASDAQ:CDNA$17.52 +0.44 (+2.58%) As of 01:15 PM EasternCareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.Privia Health Group NASDAQ:PRVA$23.03 +0.20 (+0.88%) As of 01:15 PM EasternPrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.Surgery Partners NASDAQ:SGRY$23.38 -0.01 (-0.04%) As of 01:10 PM EasternSurgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.Sotera Health NASDAQ:SHC$12.30 +0.11 (+0.90%) As of 01:15 PM EasternSotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Broadcom Earnings Preview: AVGO Stock Near Record Highs Why Super Micro Computer's Upside Could Trigger a Short Squeeze Zscaler Will Hit $360 Soon: Here’s the How and Why Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
